Table 2.
Primers used for site-directed mutagenesis of HPV18 E4 sequence.
Primera | Sequence (5′ to 3′) |
---|---|
T23I | GCTACAGCATCCCACCTACAGG |
RXL1 | CCACCGCCAGGCATAGGCGGCTGCACGACCTG |
RXL2 | CCGCCAGGAGGCCGCTGCGGCACGACCTGGAC |
RXLD | CCACCGCCAGGCATCCGCGGCGGCACGACCTGGAC |
Δ21-23 | CTCAGCCTGCTCAACAGCCCACCTCACAGGATCCCC |
S22N | GCTTGTTAAACAGCTACAACACACCCCCTCACCGT |
∞ T23I | GTTAAACAGCTACAGCATACCCCCTCACCG |
∞ RXL1 | CCTACGGCCAGACATCGGCGGCTACACGACCTG |
∞ RXL2 | GCCAGACGTCCGCTGCGACACGACCTG |
∞ RXLD | GACCTACGGCCAGACATCCGCGGCGACACGACCTGGAC |
Nucleotides underlined denotes altered nucleotide.
Primers used to construct mutations in GST-HPV18E1^E4 coding sequence, recombinant adenovirus-HPV18 E1^E4 sequence and in HPV18 genomic DNA.